Verdecchia P, Angeli F, Reboldi G. Hypertension and atrial fibrillation: doubts and certainties from basic and clinical studies. Circ Res. 2018;122(2):352–68. https://doi.org/10.1161/CIRCRESAHA.117.311402.

Article  CAS  PubMed  Google Scholar 

Nabauer M, Gerth A, Limbourg T, et al. The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management. Europace. 2009;11(4):423–34. https://doi.org/10.1093/europace/eun369.

Article  PubMed  PubMed Central  Google Scholar 

Benjamin EJ, Levy D, Vaziri SM, D’Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994;271(11):840–4.

Article  CAS  PubMed  Google Scholar 

Conen D, Tedrow UB, Koplan BA, Glynn RJ, Buring JE, Albert CM. Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women. Circulation. 2009;119(16):2146–52. https://doi.org/10.1161/CIRCULATIONAHA.108.830042.

Article  PubMed  PubMed Central  Google Scholar 

Vaziri SM, Larson MG, Lauer MS, Benjamin EJ, Levy D. Influence of blood pressure on left atrial size. The Framingham Heart Study. Hypertension. 1995;25(6):1155–60. https://doi.org/10.1161/01.hyp.25.6.1155.

Article  CAS  PubMed  Google Scholar 

Kahan T, Bergfeldt L. Left ventricular hypertrophy in hypertension: its arrhythmogenic potential. Heart. 2005;91(2):250–6. https://doi.org/10.1136/hrt.2004.042473.

Article  PubMed  PubMed Central  Google Scholar 

Mancia G, Grassi G, Giannattasio C, Seravalle G. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage. Hypertension. 1999;34(4 Pt 2):724–8. https://doi.org/10.1161/01.hyp.34.4.724.

Article  CAS  PubMed  Google Scholar 

Carnagarin R, Kiuchi MG, Ho JK, Matthews VB, Schlaich MP. Sympathetic nervous system activation and its modulation: role in atrial fibrillation. Front Neurosci. 2018;12:1058. https://doi.org/10.3389/fnins.2018.01058.

Article  PubMed  Google Scholar 

Nair GM, Nery PB, Redpath CJ, Birnie DH. The role of renin angiotensin system in atrial fibrillation. J Atr Fibrillation. 2014;6(6):972. https://doi.org/10.4022/jafib.972.

Article  PubMed  PubMed Central  Google Scholar 

Soliman EZ, Rahman AF, Zhang ZM, et al. Effect of intensive blood pressure lowering on the risk of atrial fibrillation. Hypertension. 2020;75(6):1491–6. https://doi.org/10.1161/HYPERTENSIONAHA.120.14766.

Article  CAS  PubMed  Google Scholar 

Aune D, Mahamat-Saleh Y, Kobeissi E, Feng T, Heath AK, Janszky I. Blood pressure, hypertension and the risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol. 2023;38(2):145–78. https://doi.org/10.1007/s10654-022-00914-0.

Article  PubMed  PubMed Central  Google Scholar 

Gumprecht J, Domek M, Lip GYH, Shantsila A. Invited review: hypertension and atrial fibrillation: epidemiology, pathophysiology, and implications for management. J Hum Hypertens. 2019;33(12):824–36. https://doi.org/10.1038/s41371-019-0279-7.

Article  PubMed  Google Scholar 

Dzeshka MS, Shantsila A, Shantsila E, Lip GYH. Atrial fibrillation and hypertension. Hypertension. 2017;70(5):854–61. https://doi.org/10.1161/HYPERTENSIONAHA.117.08934.

Article  CAS  PubMed  Google Scholar 

McNeil JJ, Wolfe R, Woods RL, et al. Effect of aspirin on cardiovascular events and bleeding in the healthy elderly. N Engl J Med. 2018;379(16):1509–18. https://doi.org/10.1056/NEJMoa1805819.

Article  CAS  PubMed  PubMed Central  Google Scholar 

McNeil JJ, Woods RL, Nelson MR, et al. Effect of aspirin on disability-free survival in the healthy elderly. N Engl J Med. 2018;379(16):1499–508. https://doi.org/10.1056/NEJMoa1800722.

Article  CAS  PubMed  PubMed Central  Google Scholar 

ASPREE Investigator Group. Study design of ASPirin in Reducing Events in the Elderly (ASPREE): a randomized, controlled trial. Contemp Clin Trials. 2013;36(2):555–64. https://doi.org/10.1016/j.cct.2013.09.014.

Article  PubMed Central  Google Scholar 

Ball J, Neumann JT, Tonkin AM, et al. Low-dose aspirin and incident atrial fibrillation in healthy older individuals: a post-hoc analysis of the ASPREE Trial. Eur Heart J Cardiovasc Pharmacother. 2023. https://doi.org/10.1093/ehjcvp/pvad082.

Article  PubMed Central  Google Scholar 

Khan SS, Matsushita K, Sang Y, et al. Development and Validation of the American Heart Association’s PREVENT Equations. Circulation. 2024;149(6):430–49. https://doi.org/10.1161/CIRCULATIONAHA.123.067626.

Article  PubMed  Google Scholar 

VanderWeele TJ. Principles of confounder selection. Eur J Epidemiol. 2019;34(3):211–9. https://doi.org/10.1007/s10654-019-00494-6.

Article  PubMed  PubMed Central  Google Scholar 

Okin PM, Wachtell K, Devereux RB, et al. Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension. JAMA. 2006;296(10):1242–8. https://doi.org/10.1001/jama.296.10.1242.

Article  CAS  PubMed  Google Scholar 

Koracevic G, Perisic Z, Stanojkovic M, et al. A discrepancy: calcium channel blockers are effective for the treatment of hypertensive left ventricular hypertrophy but not as effective for prevention of heart failure. Med Princ Pract. 2022;31(5):454–62. https://doi.org/10.1159/000526792.

Article  PubMed  PubMed Central  Google Scholar 

Kaze AD, Yuyun MF, Fonarow GC, Echouffo-Tcheugui JB. Blood pressure variability and risk of atrial fibrillation in adults with type 2 diabetes. JACC Adv. 2023. https://doi.org/10.1016/j.jacadv.2023.100382.

Article  PubMed  PubMed Central  Google Scholar 

Konstantinou K, Apostolos A, Tsiachris D, et al. Exploring the link between blood pressure variability and atrial fibrillation: current insights and future directions. J Hum Hypertens. 2024;38(8):583–94. https://doi.org/10.1038/s41371-024-00936-z.

Article  PubMed  Google Scholar 

de Havenon A, Petersen N, Wolcott Z, et al. Effect of dihydropyridine calcium channel blockers on blood pressure variability in the SPRINT trial: a treatment effects approach. J Hypertens. 2022;40(3):462–9. https://doi.org/10.1097/HJH.0000000000003033.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hansson L, Lindholm LH, Ekbom T, et al. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Lancet. 1999;354(9192):1751–6. https://doi.org/10.1016/s0140-6736(99)10327-1.

Article  CAS  PubMed  Google Scholar 

Haywood LJ, Ford CE, Crow RS, et al. Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial). J Am Coll Cardiol. 2009;54(22):2023–31. https://doi.org/10.1016/j.jacc.2009.08.020.

Article  CAS  PubMed  Google Scholar 

Marott SC, Nielsen SF, Benn M, Nordestgaard BG. Antihypertensive treatment and risk of atrial fibrillation: a nationwide study. Eur Heart J. 2014;35(18):1205–14. https://doi.org/10.1093/eurheartj/eht507.

Article  CAS  PubMed  Google Scholar 

Iravanian S, Dudley SC Jr. The renin-angiotensin-aldosterone system (RAAS) and cardiac arrhythmias. Heart Rhythm. 2008;5(6 Suppl):S12–7. https://doi.org/10.1016/j.hrthm.2008.02.025.

Article  PubMed  PubMed Central